Apr 26, 2016
Last December, Congress passed a federal spending budget that included the largest funding increase for the National Institutes of Health (NIH) and National Cancer Institute (NCI) in over a decade. This funding increase was an important milestone for the cancer community, taking the first step to strengthen the nation’s investment in cancer research after years of stagnant funding.
While applauding Congress for this progress, ASCO’s advocacy efforts continue to urge lawmakers to sustain federal investment and restore the country’s biomedical research infrastructure. Even with last year’s funding increase, Congressional appropriations for NIH have failed to keep pace with inflation over the last decade. The lack of adequate federal biomedical research funding has had a wide-ranging impact on cancer research, according to ASCO, with dramatically lower grant application success rates and less money available for new researchers seeking their first grant.